[{"Assets_0_Q2_USD":7802000000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.105,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.21,"CommonStockSharesOutstanding_0_Q2_shares":489659511.0,"EarningsPerShareBasic_1_Q2_USD":0.5,"EarningsPerShareBasic_2_Q2_USD":0.99,"EarningsPerShareDiluted_1_Q2_USD":0.5,"EarningsPerShareDiluted_2_Q2_USD":0.98,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":299000000.0,"NetIncomeLoss_1_Q2_USD":247000000.0,"NetIncomeLoss_2_Q2_USD":485000000.0,"StockholdersEquity_0_Q2_USD":1715000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":494000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":494600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":490800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":491600000.0,"Ticker":"ZTS","CIK":"1555280","name":"ZOETIS INC.","OfficialName":"Zoetis Inc. Class A Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"87624320945.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170808"}]